DrugSupplement
Ribose clinical trials
- studies test it
- 9
- open now
- 0
- in phase 3
- 0
- first study started
- 1995
How studies write it
Studies that test it under each name
Studies by the year they started
9 studies that test it; most in 2006 (2)
| Year | Studies |
|---|---|
| 1995 | 1 |
| 2006 | 2 |
| 2009 | 2 |
| 2011 | 1 |
| 2013 | 1 |
| 2014 | 1 |
| 2018 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 2
- 4
- No phase
- 5
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 5 · Other 4
RiboCor, Inc. (2) · Bioenergy Life Science, Inc. (2) · University of Kansas Medical Center (1) · Kona Research Center (1) · National Center for Research Resources (NCRR) (1) · Practitioners Alliance Network (1) · Valen Labs (1)
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses Ribose is read from its arms, and is right about nine times in ten.
Testing it · 9
- CoQ10 and D-ribose in Patients With Diastolic Heart FailureCompletedPhase 2University of Kansas Medical CenterNCT03133793Written as D-Ribose Oral Powder
- Treating Alzheimer's and Dementia With D-riboseTerminatedNot applicablePractitioners Alliance NetworkNCT02260141Written as d-ribose
- Study To Evaluate D-Ribose For The Treatment of Congestive Heart FailureWithdrawnPhase 2RiboCor, Inc.NCT01858480Written as D-ribose
- D-Ribose for Fatigue in Subjects With FibromyalgiaCompletedPhase 2RiboCor, Inc.NCT01315210Written as D-Ribose Powder
- Treatment of Chronic Fatigue Syndrome and Fibromyalgia With D-ribose- a Multicenter StudyCompletedNot applicableKona Research CenterNCT01108549Written as Ribose
- The Effect of Oral D-Ribose in "Baby Boomers" With Fatigue. A Randomized, Double-Blind StudyCompletedNot applicableBioenergy Life Science, Inc.NCT00821067Written as D-ribose
- The Role of Ribose in Patients Diagnosed With FibromyalgiaSuspendedNot applicableBioenergy Life Science, Inc.NCT00566514Written as D-ribose
- The Effect of Ribose on B-Type Natriuretic Peptide (BNP) Levels in Congestive Heart Failure PatientsTerminatedNot applicableValen LabsNCT00329485Written as CORvalen (D-Ribose)
- Phase II Study of Ribose, Uridine, and Thymidine for a Complex Syndrome Involving Excessive 5'-Nucleotidase ActivityCompletedPhase 2National Center for Research Resources (NCRR)NCT00004658Written as ribose
Codes
What other systems call Ribose · ClinicalTrials.gg INT008162
- MeSH (NLM) D012266RiboseOne source NLM
- UNII (FDA) 681HV46001RIBOSE, D-Confirmed FDA, NLM, Wikidata
- RxNorm 1314858Confirmed FDA, Wikidata
- Wikidata Q27120759aldehydo-D-riboseConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C68487RiboseOne source FDA
- DrugBank DB15073One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D012266 | Ribose | One source NLM |
| UNII (FDA) | 681HV46001 | RIBOSE, D- | Confirmed FDA, NLM, Wikidata |
| RxNorm | 1314858 | — | Confirmed FDA, Wikidata |
| Wikidata | Q27120759 | aldehydo-D-ribose | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C68487 | Ribose | One source FDA |
| DrugBank | DB15073 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.